🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/08/2015 | 168,68 | 172,39 | 166,84 | 167,58 | -0,59% | 3,29% | 521.200 |
| 17/08/2015 | 163,74 | 168,85 | 162,30 | 168,58 | +2,33% | 4,00% | 422.600 |
| 14/08/2015 | 164,33 | 165,60 | 162,44 | 164,74 | -0,08% | 1,92% | 317.100 |
| 13/08/2015 | 164,90 | 166,79 | 163,47 | 164,88 | +0,43% | 2,01% | 335.300 |
| 12/08/2015 | 162,49 | 165,31 | 160,74 | 164,17 | -0,60% | 2,81% | 563.500 |
| 11/08/2015 | 163,27 | 166,87 | 161,72 | 165,16 | +0,10% | 3,15% | 442.700 |
| 10/08/2015 | 166,66 | 168,94 | 163,80 | 165,00 | +0,00% | 3,08% | 417.400 |
| 07/08/2015 | 158,65 | 165,68 | 155,56 | 165,00 | +3,35% | 6,38% | 667.100 |
| 06/08/2015 | 167,41 | 167,50 | 158,42 | 159,65 | -4,14% | 5,42% | 589.800 |
| 05/08/2015 | 165,33 | 170,03 | 165,32 | 166,55 | +1,72% | 2,85% | 473.500 |
| 04/08/2015 | 164,51 | 165,84 | 162,22 | 163,73 | +0,29% | 2,20% | 452.500 |
| 03/08/2015 | 170,04 | 170,29 | 162,04 | 163,25 | -3,61% | 4,85% | 716.500 |
| 31/07/2015 | 163,79 | 169,71 | 162,51 | 169,36 | +4,04% | 4,40% | 1.048.100 |
| 30/07/2015 | 166,10 | 166,10 | 157,99 | 162,79 | -2,63% | 4,88% | 709.400 |
| 29/07/2015 | 166,32 | 168,50 | 164,07 | 167,18 | +0,74% | 2,66% | 714.500 |
| 28/07/2015 | 157,00 | 169,94 | 152,02 | 165,96 | +0,11% | 11,41% | 1.597.800 |
| 27/07/2015 | 168,68 | 169,39 | 164,07 | 165,78 | -2,07% | 3,15% | 808.100 |
| 24/07/2015 | 174,11 | 175,66 | 168,68 | 169,28 | -3,32% | 4,01% | 435.200 |
| 23/07/2015 | 175,74 | 176,84 | 173,78 | 175,10 | +0,29% | 1,74% | 323.600 |
| 22/07/2015 | 173,73 | 175,53 | 173,33 | 174,60 | -0,33% | 1,27% | 329.000 |
| 21/07/2015 | 177,54 | 179,37 | 174,44 | 175,17 | -1,32% | 2,78% | 378.300 |
| 20/07/2015 | 179,66 | 180,40 | 177,06 | 177,51 | -0,92% | 1,86% | 446.800 |
| 17/07/2015 | 178,69 | 179,60 | 176,84 | 179,15 | +0,75% | 1,54% | 511.900 |
| 16/07/2015 | 177,10 | 178,12 | 174,30 | 177,81 | +0,78% | 2,16% | 538.800 |
| 15/07/2015 | 175,42 | 181,03 | 174,71 | 176,43 | +0,79% | 3,60% | 655.500 |
| 14/07/2015 | 171,57 | 175,12 | 171,18 | 175,05 | +1,69% | 2,30% | 522.100 |
| 13/07/2015 | 172,91 | 174,29 | 171,00 | 172,14 | +0,33% | 1,90% | 346.900 |
| 10/07/2015 | 171,26 | 172,55 | 169,44 | 171,57 | +2,31% | 1,82% | 445.800 |
| 09/07/2015 | 168,81 | 170,11 | 166,74 | 167,69 | +0,83% | 2,00% | 512.300 |
| 08/07/2015 | 169,49 | 171,07 | 165,53 | 166,31 | -2,61% | 3,27% | 657.900 |